FTDWX
Price
$14.01
Change
-$0.00 (-0.00%)
Updated
Aug 8 closing price
Net Assets
5.49B
JSLCX
Price
$12.16
Change
-$0.00 (-0.00%)
Updated
Aug 8 closing price
Net Assets
1.58B
Interact to see
Advertisement

FTDWX vs JSLCX

Header iconFTDWX vs JSLCX Comparison
Open Charts FTDWX vs JSLCXBanner chart's image
Fidelity Advisor Asset Manager 20% M
Price$14.01
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets5.49B
JHancock Multimanager Lifestyle Cnsrv R4
Price$12.16
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets1.58B
FTDWX vs JSLCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FTDWX vs. JSLCX commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTDWX is a Buy and JSLCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTDWX has more cash in the bank: 5.49B vs. JSLCX (1.58B). JSLCX pays higher dividends than FTDWX: JSLCX (3.85) vs FTDWX (2.70). FTDWX was incepted earlier than JSLCX: FTDWX (19 years) vs JSLCX (20 years). JSLCX (1.17) is less costly to investors than FTDWX (1.02). FTDWX is a more actively managed with annual turnover of: 24.00 vs. JSLCX (16.00). FTDWX (0) and JSLCX (0) have matching initial minimum investment requirements. JSLCX annual gain was more profitable for investors over the last year : 7.42 vs. FTDWX (6.74). FTDWX return over 5 years is better than : 10.18 vs. JSLCX (8.43).
FTDWXJSLCXFTDWX / JSLCX
Total Expense Ratio1.021.0795%
Annual Report Gross Expense Ratio1.021.1787%
Fund Existence19 years20 years-
Gain YTD5.2455.50295%
Front Load4%N/A-
Min. Initial Investment00-
Min. Initial Investment IRA500N/A-
Net Assets5.49B1.58B347%
Annual Yield % from dividends2.703.8570%
Returns for 1 year6.747.4291%
Returns for 3 years12.2314.7883%
Returns for 5 years10.188.43121%
Returns for 10 years23.0424.6094%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLVLY7.820.01
+0.19%
Clinuvel Pharmaceuticals Ltd.
TOIPF1.00N/A
N/A
Thai Oil Public Co., Ltd.
ACITF0.20N/A
N/A
Asian Citrus Holdings Ltd.
OPHRF0.04N/A
N/A
OPHIR METALS CORP.